AustralieFrV1, PascalFrancis, Corpus, bibRecord, 001224

Childhood tuberculosis: progress requires an advocacy strategy now

Identifieur interne : 001224 ( PascalFrancis/Corpus ); précédent : 001223; suivant : 001225

Childhood tuberculosis: progress requires an advocacy strategy now

Auteurs : Andreas Sandgren ; Luis E. Cuevas ; Masoud Dara ; Robert P. Gie ; Malgorzata Grzemska ; Anthony Hawkridge ; Anneke C. Hesseling ; Beate Kampmann ; Christian Lienhardt ; Davide Manissero ; Claire Wingfield ; Stephen M. Graham

Source :

The European respiratory journal [ 0903-1936 ] ; 2012.

RBID : Pascal:12-0307329

Descripteurs français

Pascal (Inist)
- Tuberculose, Enfant, Stratégie, Commande, Mycobacterium tuberculosis, Santé publique, Pneumologie.

English descriptors

KwdEn :
- Child, Control, Mycobacterium tuberculosis, Pneumology, Public health, Strategy, Tuberculosis.

Abstract

Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0903-1936`
A03		`1`		`@0 Eur. respir. j.`
A05				`@2 40`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Childhood tuberculosis: progress requires an advocacy strategy now`
A11	`01`	`1`		`@1 SANDGREN (Andreas)`
A11	`02`	`1`		`@1 CUEVAS (Luis E.)`
A11	`03`	`1`		`@1 DARA (Masoud)`
A11	`04`	`1`		`@1 GIE (Robert P.)`
A11	`05`	`1`		`@1 GRZEMSKA (Malgorzata)`
A11	`06`	`1`		`@1 HAWKRIDGE (Anthony)`
A11	`07`	`1`		`@1 HESSELING (Anneke C.)`
A11	`08`	`1`		`@1 KAMPMANN (Beate)`
A11	`09`	`1`		`@1 LIENHARDT (Christian)`
A11	`10`	`1`		`@1 MANISSERO (Davide)`
A11	`11`	`1`		`@1 WINGFIELD (Claire)`
A11	`12`	`1`		`@1 GRAHAM (Stephen M.)`
A14	`01`			`@1 A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control @2 Stockholm @3 SWE @Z 1 aut. @Z 10 aut.`
A14	`02`			`@1 L.E. Cuevas, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases @2 Geneva @3 CHE @Z 2 aut.`
A14	`03`			`@1 M. Dara, World Health Organization, Regional Office for Europe @2 Copenhagen @3 DNK @Z 3 aut.`
A14	`04`			`@1 R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University @2 Stellenbosch @3 ZAF @Z 4 aut. @Z 7 aut.`
A14	`05`			`@1 M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization @2 Geneva @3 CHE @Z 5 aut. @Z 9 aut.`
A14	`06`			`@1 A. Hawkridge, Institute of Infectious Disease and Molecular Medicine, University of Cape Town @2 Cape Town @3 ZAF @Z 6 aut.`
A14	`07`			`@1 B. Kampmann, Dept of Paediatrics, Imperial College @2 London @3 GBR @Z 8 aut.`
A14	`08`			`@1 Medical Research Council Unit The Gambia @2 Banjul @3 GMB @Z 8 aut.`
A14	`09`			`@1 C. Wingfield, Treatment Action Group @2 New York, NY @3 USA @Z 11 aut.`
A14	`10`			`@1 S.M. Graham, Centre for International Child Health, University of Melbourne, Dept of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital @2 Melbourne @3 AUS @Z 12 aut.`
A14	`11`			`@1 International Union Against Tuberculosis and Lung Disease @2 Paris @3 FRA @Z 12 aut.`
A20				`@1 294-297`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 4275 @5 354000504047230050`
A44				`@0 0000 @1 © 2012 INIST-CNRS. All rights reserved.`
A45				`@0 18 ref.`
A47	`01`	`1`		`@0 12-0307329`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 The European respiratory journal`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.
C02	`01`	`X`		`@0 002B11`
C02	`02`	`X`		`@0 002B05B02O`
C03	`01`	`X`	`FRE`	`@0 Tuberculose @5 01`
C03	`01`	`X`	`ENG`	`@0 Tuberculosis @5 01`
C03	`01`	`X`	`SPA`	`@0 Tuberculosis @5 01`
C03	`02`	`X`	`FRE`	`@0 Enfant @5 09`
C03	`02`	`X`	`ENG`	`@0 Child @5 09`
C03	`02`	`X`	`SPA`	`@0 Niño @5 09`
C03	`03`	`X`	`FRE`	`@0 Stratégie @5 10`
C03	`03`	`X`	`ENG`	`@0 Strategy @5 10`
C03	`03`	`X`	`SPA`	`@0 Estrategia @5 10`
C03	`04`	`X`	`FRE`	`@0 Commande @5 11`
C03	`04`	`X`	`ENG`	`@0 Control @5 11`
C03	`04`	`X`	`SPA`	`@0 Control @5 11`
C03	`05`	`X`	`FRE`	`@0 Mycobacterium tuberculosis @2 NS @5 12`
C03	`05`	`X`	`ENG`	`@0 Mycobacterium tuberculosis @2 NS @5 12`
C03	`05`	`X`	`SPA`	`@0 Mycobacterium tuberculosis @2 NS @5 12`
C03	`06`	`X`	`FRE`	`@0 Santé publique @5 13`
C03	`06`	`X`	`ENG`	`@0 Public health @5 13`
C03	`06`	`X`	`SPA`	`@0 Salud pública @5 13`
C03	`07`	`X`	`FRE`	`@0 Pneumologie @5 14`
C03	`07`	`X`	`ENG`	`@0 Pneumology @5 14`
C03	`07`	`X`	`SPA`	`@0 Neumología @5 14`
C07	`01`	`X`	`FRE`	`@0 Mycobactériose`
C07	`01`	`X`	`ENG`	`@0 Mycobacterial infection`
C07	`01`	`X`	`SPA`	`@0 Micobacteriosis`
C07	`02`	`X`	`FRE`	`@0 Bactériose`
C07	`02`	`X`	`ENG`	`@0 Bacteriosis`
C07	`02`	`X`	`SPA`	`@0 Bacteriosis`
C07	`03`	`X`	`FRE`	`@0 Infection`
C07	`03`	`X`	`ENG`	`@0 Infection`
C07	`03`	`X`	`SPA`	`@0 Infección`
C07	`04`	`X`	`FRE`	`@0 Homme`
C07	`04`	`X`	`ENG`	`@0 Human`
C07	`04`	`X`	`SPA`	`@0 Hombre`
C07	`05`	`X`	`FRE`	`@0 Mycobacteriaceae @2 NS`
C07	`05`	`X`	`ENG`	`@0 Mycobacteriaceae @2 NS`
C07	`05`	`X`	`SPA`	`@0 Mycobacteriaceae @2 NS`
C07	`06`	`X`	`FRE`	`@0 Mycobacteriales @2 NS`
C07	`06`	`X`	`ENG`	`@0 Mycobacteriales @2 NS`
C07	`06`	`X`	`SPA`	`@0 Mycobacteriales @2 NS`
C07	`07`	`X`	`FRE`	`@0 Actinomycetes @2 NS`
C07	`07`	`X`	`ENG`	`@0 Actinomycetes @2 NS`
C07	`07`	`X`	`SPA`	`@0 Actinomycetes @2 NS`
C07	`08`	`X`	`FRE`	`@0 Bactérie`
C07	`08`	`X`	`ENG`	`@0 Bacteria`
C07	`08`	`X`	`SPA`	`@0 Bacteria`
N21				`@1 233`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 12-0307329 INIST
ET :	Childhood tuberculosis: progress requires an advocacy strategy now
AU :	SANDGREN (Andreas); CUEVAS (Luis E.); DARA (Masoud); GIE (Robert P.); GRZEMSKA (Malgorzata); HAWKRIDGE (Anthony); HESSELING (Anneke C.); KAMPMANN (Beate); LIENHARDT (Christian); MANISSERO (Davide); WINGFIELD (Claire); GRAHAM (Stephen M.)
AF :	A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control/Stockholm/Suède (1 aut., 10 aut.); L.E. Cuevas, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases/Geneva/Suisse (2 aut.); M. Dara, World Health Organization, Regional Office for Europe/Copenhagen/Danemark (3 aut.); R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University/Stellenbosch/Afrique du Sud (4 aut., 7 aut.); M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization/Geneva/Suisse (5 aut., 9 aut.); A. Hawkridge, Institute of Infectious Disease and Molecular Medicine, University of Cape Town/Cape Town/Afrique du Sud (6 aut.); B. Kampmann, Dept of Paediatrics, Imperial College/London/Royaume-Uni (8 aut.); Medical Research Council Unit The Gambia/Banjul/Gambie (8 aut.); C. Wingfield, Treatment Action Group/New York, NY/Etats-Unis (11 aut.); S.M. Graham, Centre for International Child Health, University of Melbourne, Dept of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital/Melbourne/Australie (12 aut.); International Union Against Tuberculosis and Lung Disease/Paris/France (12 aut.)
DT :	Publication en série; Niveau analytique
SO :	The European respiratory journal; ISSN 0903-1936; Royaume-Uni; Da. 2012; Vol. 40; No. 2; Pp. 294-297; Bibl. 18 ref.
LA :	Anglais
EA :	Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.
CC :	002B11; 002B05B02O
FD :	Tuberculose; Enfant; Stratégie; Commande; Mycobacterium tuberculosis; Santé publique; Pneumologie
FG :	Mycobactériose; Bactériose; Infection; Homme; Mycobacteriaceae; Mycobacteriales; Actinomycetes; Bactérie
ED :	Tuberculosis; Child; Strategy; Control; Mycobacterium tuberculosis; Public health; Pneumology
EG :	Mycobacterial infection; Bacteriosis; Infection; Human; Mycobacteriaceae; Mycobacteriales; Actinomycetes; Bacteria
SD :	Tuberculosis; Niño; Estrategia; Control; Mycobacterium tuberculosis; Salud pública; Neumología
LO :	INIST-4275.354000504047230050
ID :	12-0307329

Links to Exploration step

Pascal:12-0307329

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Childhood tuberculosis: progress requires an advocacy strategy now</title>
<author><name sortKey="Sandgren, Andreas" sort="Sandgren, Andreas" uniqKey="Sandgren A" first="Andreas" last="Sandgren">Andreas Sandgren</name>
<affiliation><inist:fA14 i1="01"><s1>A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cuevas, Luis E" sort="Cuevas, Luis E" uniqKey="Cuevas L" first="Luis E." last="Cuevas">Luis E. Cuevas</name>
<affiliation><inist:fA14 i1="02"><s1>L.E. Cuevas, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dara, Masoud" sort="Dara, Masoud" uniqKey="Dara M" first="Masoud" last="Dara">Masoud Dara</name>
<affiliation><inist:fA14 i1="03"><s1>M. Dara, World Health Organization, Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gie, Robert P" sort="Gie, Robert P" uniqKey="Gie R" first="Robert P." last="Gie">Robert P. Gie</name>
<affiliation><inist:fA14 i1="04"><s1>R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University</s1>
<s2>Stellenbosch</s2>
<s3>ZAF</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grzemska, Malgorzata" sort="Grzemska, Malgorzata" uniqKey="Grzemska M" first="Malgorzata" last="Grzemska">Malgorzata Grzemska</name>
<affiliation><inist:fA14 i1="05"><s1>M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hawkridge, Anthony" sort="Hawkridge, Anthony" uniqKey="Hawkridge A" first="Anthony" last="Hawkridge">Anthony Hawkridge</name>
<affiliation><inist:fA14 i1="06"><s1>A. Hawkridge, Institute of Infectious Disease and Molecular Medicine, University of Cape Town</s1>
<s2>Cape Town</s2>
<s3>ZAF</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hesseling, Anneke C" sort="Hesseling, Anneke C" uniqKey="Hesseling A" first="Anneke C." last="Hesseling">Anneke C. Hesseling</name>
<affiliation><inist:fA14 i1="04"><s1>R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University</s1>
<s2>Stellenbosch</s2>
<s3>ZAF</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kampmann, Beate" sort="Kampmann, Beate" uniqKey="Kampmann B" first="Beate" last="Kampmann">Beate Kampmann</name>
<affiliation><inist:fA14 i1="07"><s1>B. Kampmann, Dept of Paediatrics, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Medical Research Council Unit The Gambia</s1>
<s2>Banjul</s2>
<s3>GMB</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lienhardt, Christian" sort="Lienhardt, Christian" uniqKey="Lienhardt C" first="Christian" last="Lienhardt">Christian Lienhardt</name>
<affiliation><inist:fA14 i1="05"><s1>M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Manissero, Davide" sort="Manissero, Davide" uniqKey="Manissero D" first="Davide" last="Manissero">Davide Manissero</name>
<affiliation><inist:fA14 i1="01"><s1>A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wingfield, Claire" sort="Wingfield, Claire" uniqKey="Wingfield C" first="Claire" last="Wingfield">Claire Wingfield</name>
<affiliation><inist:fA14 i1="09"><s1>C. Wingfield, Treatment Action Group</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Graham, Stephen M" sort="Graham, Stephen M" uniqKey="Graham S" first="Stephen M." last="Graham">Stephen M. Graham</name>
<affiliation><inist:fA14 i1="10"><s1>S.M. Graham, Centre for International Child Health, University of Melbourne, Dept of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>International Union Against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0307329</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0307329 INIST</idno>
<idno type="RBID">Pascal:12-0307329</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001224</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Childhood tuberculosis: progress requires an advocacy strategy now</title>
<author><name sortKey="Sandgren, Andreas" sort="Sandgren, Andreas" uniqKey="Sandgren A" first="Andreas" last="Sandgren">Andreas Sandgren</name>
<affiliation><inist:fA14 i1="01"><s1>A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cuevas, Luis E" sort="Cuevas, Luis E" uniqKey="Cuevas L" first="Luis E." last="Cuevas">Luis E. Cuevas</name>
<affiliation><inist:fA14 i1="02"><s1>L.E. Cuevas, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dara, Masoud" sort="Dara, Masoud" uniqKey="Dara M" first="Masoud" last="Dara">Masoud Dara</name>
<affiliation><inist:fA14 i1="03"><s1>M. Dara, World Health Organization, Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gie, Robert P" sort="Gie, Robert P" uniqKey="Gie R" first="Robert P." last="Gie">Robert P. Gie</name>
<affiliation><inist:fA14 i1="04"><s1>R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University</s1>
<s2>Stellenbosch</s2>
<s3>ZAF</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grzemska, Malgorzata" sort="Grzemska, Malgorzata" uniqKey="Grzemska M" first="Malgorzata" last="Grzemska">Malgorzata Grzemska</name>
<affiliation><inist:fA14 i1="05"><s1>M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hawkridge, Anthony" sort="Hawkridge, Anthony" uniqKey="Hawkridge A" first="Anthony" last="Hawkridge">Anthony Hawkridge</name>
<affiliation><inist:fA14 i1="06"><s1>A. Hawkridge, Institute of Infectious Disease and Molecular Medicine, University of Cape Town</s1>
<s2>Cape Town</s2>
<s3>ZAF</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hesseling, Anneke C" sort="Hesseling, Anneke C" uniqKey="Hesseling A" first="Anneke C." last="Hesseling">Anneke C. Hesseling</name>
<affiliation><inist:fA14 i1="04"><s1>R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University</s1>
<s2>Stellenbosch</s2>
<s3>ZAF</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kampmann, Beate" sort="Kampmann, Beate" uniqKey="Kampmann B" first="Beate" last="Kampmann">Beate Kampmann</name>
<affiliation><inist:fA14 i1="07"><s1>B. Kampmann, Dept of Paediatrics, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Medical Research Council Unit The Gambia</s1>
<s2>Banjul</s2>
<s3>GMB</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lienhardt, Christian" sort="Lienhardt, Christian" uniqKey="Lienhardt C" first="Christian" last="Lienhardt">Christian Lienhardt</name>
<affiliation><inist:fA14 i1="05"><s1>M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Manissero, Davide" sort="Manissero, Davide" uniqKey="Manissero D" first="Davide" last="Manissero">Davide Manissero</name>
<affiliation><inist:fA14 i1="01"><s1>A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wingfield, Claire" sort="Wingfield, Claire" uniqKey="Wingfield C" first="Claire" last="Wingfield">Claire Wingfield</name>
<affiliation><inist:fA14 i1="09"><s1>C. Wingfield, Treatment Action Group</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Graham, Stephen M" sort="Graham, Stephen M" uniqKey="Graham S" first="Stephen M." last="Graham">Stephen M. Graham</name>
<affiliation><inist:fA14 i1="10"><s1>S.M. Graham, Centre for International Child Health, University of Melbourne, Dept of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>International Union Against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">The European respiratory journal</title>
<title level="j" type="abbreviated">Eur. respir. j.</title>
<idno type="ISSN">0903-1936</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">The European respiratory journal</title>
<title level="j" type="abbreviated">Eur. respir. j.</title>
<idno type="ISSN">0903-1936</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Child</term>
<term>Control</term>
<term>Mycobacterium tuberculosis</term>
<term>Pneumology</term>
<term>Public health</term>
<term>Strategy</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Tuberculose</term>
<term>Enfant</term>
<term>Stratégie</term>
<term>Commande</term>
<term>Mycobacterium tuberculosis</term>
<term>Santé publique</term>
<term>Pneumologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0903-1936</s0>
</fA01>
<fA03 i2="1"><s0>Eur. respir. j.</s0>
</fA03>
<fA05><s2>40</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Childhood tuberculosis: progress requires an advocacy strategy now</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SANDGREN (Andreas)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CUEVAS (Luis E.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DARA (Masoud)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GIE (Robert P.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GRZEMSKA (Malgorzata)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>HAWKRIDGE (Anthony)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>HESSELING (Anneke C.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>KAMPMANN (Beate)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>LIENHARDT (Christian)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MANISSERO (Davide)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>WINGFIELD (Claire)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>GRAHAM (Stephen M.)</s1>
</fA11>
<fA14 i1="01"><s1>A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>L.E. Cuevas, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>M. Dara, World Health Organization, Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University</s1>
<s2>Stellenbosch</s2>
<s3>ZAF</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>A. Hawkridge, Institute of Infectious Disease and Molecular Medicine, University of Cape Town</s1>
<s2>Cape Town</s2>
<s3>ZAF</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>B. Kampmann, Dept of Paediatrics, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Medical Research Council Unit The Gambia</s1>
<s2>Banjul</s2>
<s3>GMB</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>C. Wingfield, Treatment Action Group</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>S.M. Graham, Centre for International Child Health, University of Melbourne, Dept of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>International Union Against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA20><s1>294-297</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>4275</s2>
<s5>354000504047230050</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>18 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0307329</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>The European respiratory journal</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B11</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05B02O</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Tuberculose</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Tuberculosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Tuberculosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Enfant</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Child</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Niño</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Stratégie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Strategy</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Estrategia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Commande</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Control</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Control</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Mycobacterium tuberculosis</s0>
<s2>NS</s2>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Mycobacterium tuberculosis</s0>
<s2>NS</s2>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Mycobacterium tuberculosis</s0>
<s2>NS</s2>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Public health</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Pneumologie</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Pneumology</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Neumología</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Mycobactériose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Mycobacterial infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Micobacteriosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Bactériose</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Mycobacteriaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mycobacteriaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Mycobacteriaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Mycobacteriales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Mycobacteriales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Mycobacteriales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Actinomycetes</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Actinomycetes</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Actinomycetes</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Bactérie</s0>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Bacteria</s0>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Bacteria</s0>
</fC07>
<fN21><s1>233</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 12-0307329 INIST</NO>
<ET>Childhood tuberculosis: progress requires an advocacy strategy now</ET>
<AU>SANDGREN (Andreas); CUEVAS (Luis E.); DARA (Masoud); GIE (Robert P.); GRZEMSKA (Malgorzata); HAWKRIDGE (Anthony); HESSELING (Anneke C.); KAMPMANN (Beate); LIENHARDT (Christian); MANISSERO (Davide); WINGFIELD (Claire); GRAHAM (Stephen M.)</AU>
<AF>A. Sandgren and D. Manissero, European Centre for Disease Prevention and Control/Stockholm/Suède (1 aut., 10 aut.); L.E. Cuevas, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases/Geneva/Suisse (2 aut.); M. Dara, World Health Organization, Regional Office for Europe/Copenhagen/Danemark (3 aut.); R.P. Gie and A.C. Hesseling, Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University/Stellenbosch/Afrique du Sud (4 aut., 7 aut.); M. Grzemska and C. Lienhardt, Stop TB Partnership, Stop TB Department, World Health Organization/Geneva/Suisse (5 aut., 9 aut.); A. Hawkridge, Institute of Infectious Disease and Molecular Medicine, University of Cape Town/Cape Town/Afrique du Sud (6 aut.); B. Kampmann, Dept of Paediatrics, Imperial College/London/Royaume-Uni (8 aut.); Medical Research Council Unit The Gambia/Banjul/Gambie (8 aut.); C. Wingfield, Treatment Action Group/New York, NY/Etats-Unis (11 aut.); S.M. Graham, Centre for International Child Health, University of Melbourne, Dept of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital/Melbourne/Australie (12 aut.); International Union Against Tuberculosis and Lung Disease/Paris/France (12 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>The European respiratory journal; ISSN 0903-1936; Royaume-Uni; Da. 2012; Vol. 40; No. 2; Pp. 294-297; Bibl. 18 ref.</SO>
<LA>Anglais</LA>
<EA>Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.</EA>
<CC>002B11; 002B05B02O</CC>
<FD>Tuberculose; Enfant; Stratégie; Commande; Mycobacterium tuberculosis; Santé publique; Pneumologie</FD>
<FG>Mycobactériose; Bactériose; Infection; Homme; Mycobacteriaceae; Mycobacteriales; Actinomycetes; Bactérie</FG>
<ED>Tuberculosis; Child; Strategy; Control; Mycobacterium tuberculosis; Public health; Pneumology</ED>
<EG>Mycobacterial infection; Bacteriosis; Infection; Human; Mycobacteriaceae; Mycobacteriales; Actinomycetes; Bacteria</EG>
<SD>Tuberculosis; Niño; Estrategia; Control; Mycobacterium tuberculosis; Salud pública; Neumología</SD>
<LO>INIST-4275.354000504047230050</LO>
<ID>12-0307329</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001224 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001224 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:12-0307329
   |texte=   Childhood tuberculosis: progress requires an advocacy strategy now
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Childhood tuberculosis: progress requires an advocacy strategy now

Childhood tuberculosis: progress requires an advocacy strategy now

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri